US 6878709
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
expired A61PA61P1/02A61P1/04
Quick answer
US patent 6878709 (3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists) held by Pharmacopeia Drug Discovery, Inc. expires Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue Apr 12 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P11/00, A61P11/06